Health Technology Net

Axial Therapeutics Announces Key Research and Development Promotions to Advance Clinical and Preclinical Pipeline of Small Molecule Microbiome Therapeutics

Staff March 29, 2023

– Phase 2b clinical trial for AB-2004 in autism irritability ongoing and enrollment anticipated to be complete by end of...

ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event

Staff March 29, 2023

Initial pipeline programs with liver delivery to address Cholestatic Diseases targeting NTCP and Cardiovascular Disease targeting B4GALT1; initiation of clinical...

Swedish Olink technology enables further development of South African research and innovation

Staff March 29, 2023

Uppsala, Sweden, March 29, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the regional proteomic...

Swedish Olink technology enables further development of South African research and innovation

Staff March 29, 2023

UPPSALA, Sweden, March 29, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the regional proteomic...

BetterLife’s Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article

Staff March 29, 2023

VANCOUVER, British Columbia, March 29, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF...

Wave Life Sciences to Present at the Guggenheim Genomic Medicines and Rare Disease Days

Staff March 29, 2023

CAMBRIDGE, Mass., March 29, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed...

Kala Pharmaceuticals Appoints Dr. Francis Mah as Chief Medical Advisor

Staff March 29, 2023

ARLINGTON, Mass., March 29, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research,...

CRISPR Therapeutics Announces Departure of Board Member

Staff March 29, 2023

ZUG, Switzerland and BOSTON, March 29, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating...

Vaxart to Present at World Vaccine Congress Washington 2023 on April 5-6

Staff March 29, 2023

SOUTH SAN FRANCISCO, Calif., March 29, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker,...

Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation

Staff March 29, 2023

Topline Data Expected in 2Q 2023SEATTLE, Wash. and VANCOUVER, British Columbia, March 29, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences,...

RAPT Therapeutics Announces Initiation of Phase 2a Trial of RPT193 in Patients with Moderate-to-Severe Asthma

Staff March 29, 2023

SOUTH SAN FRANCISCO, Calif., March 29, 2023 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company...

Cocrystal Pharma Reports 2022 Financial Results and Provides Updates on its Antiviral Drug Development Programs

Staff March 29, 2023

BOTHELL, Wash., March 29, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) reports financial results for the 12 months...

QIAGEN’s QIAxcel Connect wins Red Dot design award

Staff March 29, 2023

International design competition recognizes high-resolution DNA or RNA capillary electrophoresis instrument // QIAxcel marks the fourth QIAGEN instrument to receive...

Poland and U.K. Regulatory Authorities – URPL and MHRA – Approve Use of New, Higher-Yielding Manufacturing Process for Nomacopan in Pivotal Clinical Study

Staff March 29, 2023

Third generation drug substance manufacturing process increases the final yield of nomacopan by at least 5-fold, improving cost efficiencies in...

Théa Open Innovation and Galimedix announce strategic partnership to develop and commercialize GAL-101, a Phase 2/3-ready small molecule, to treat ophthalmic indications with high unmet medical need

Staff March 29, 2023

Galimedix eligible for upfront payment plus various success-based milestone payments and royalties on future net salesEquity investment by Théa Open...

G MEDICAL INNOVATIONS AND ADVENTHEALTH IN JOINT COLLABORATION TO PROVIDE INNOVATIVE REMOTE PATIENT MONITORING SOLUTIONS FOR ADVENTHEALTH PATIENTS IN CENTRAL FLORIDA

Staff March 29, 2023

Rehovot, Israel, March 29, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company” or “G Medical...

PolyPid Announces Pricing of $6.2 Million Underwritten Public Offering of Ordinary Shares and Concurrent $4.4 Million Private Placement of Pre-Funded Warrants

Staff March 29, 2023

PETACH TIKVA, Israel, March 29, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming...

Health Technology Net

Did You Know?

The Case for Cardiovascular Collaboration: Why Platform Partnerships Drive Greater Practice Impact

Yonsei University Researchers Develop Deep Learning Model for Microsatellite Instability-High Tumor Prediction

AI Technology Could Dramatically Lower Lung Cancer Mortality Rates

The Relationship Between CMS Star Ratings and Financial Improvement

The Future of Ultrasound Reporting

Editor’s Picks

Being a Practice Owner Doesn’t Mean Skipping Holidays—Here’s How You Can Prepare

$35 Insulin: How The Program Came To Be, Who Did It And How Can You Use It?

CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

Private Wellness Club Continuum Unlocks Final Membership Tier at West Village Flagship

Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

KLAS Report Shows Strong Early Results for TrustCommerce Cloud Payments

BioFlorida Announces Appointment of Dr. Anthony Japour, CEO of iTolerance, Inc., as Chair of the Southeast Chapter

Axial Therapeutics Announces Key Research and Development Promotions to Advance Clinical and Preclinical Pipeline of Small Molecule Microbiome Therapeutics

ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event

Swedish Olink technology enables further development of South African research and innovation

Swedish Olink technology enables further development of South African research and innovation

BetterLife’s Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article

Wave Life Sciences to Present at the Guggenheim Genomic Medicines and Rare Disease Days

Kala Pharmaceuticals Appoints Dr. Francis Mah as Chief Medical Advisor

CRISPR Therapeutics Announces Departure of Board Member

Vaxart to Present at World Vaccine Congress Washington 2023 on April 5-6

Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation

RAPT Therapeutics Announces Initiation of Phase 2a Trial of RPT193 in Patients with Moderate-to-Severe Asthma

Cocrystal Pharma Reports 2022 Financial Results and Provides Updates on its Antiviral Drug Development Programs

QIAGEN’s QIAxcel Connect wins Red Dot design award

Poland and U.K. Regulatory Authorities – URPL and MHRA – Approve Use of New, Higher-Yielding Manufacturing Process for Nomacopan in Pivotal Clinical Study

Théa Open Innovation and Galimedix announce strategic partnership to develop and commercialize GAL-101, a Phase 2/3-ready small molecule, to treat ophthalmic indications with high unmet medical need

G MEDICAL INNOVATIONS AND ADVENTHEALTH IN JOINT COLLABORATION TO PROVIDE INNOVATIVE REMOTE PATIENT MONITORING SOLUTIONS FOR ADVENTHEALTH PATIENTS IN CENTRAL FLORIDA

PolyPid Announces Pricing of $6.2 Million Underwritten Public Offering of Ordinary Shares and Concurrent $4.4 Million Private Placement of Pre-Funded Warrants

Avalo Reports 2022 Financial Results and Provides Business Updates

PDS Biotech to Participate in Cantor’s Future of Oncology Virtual Symposium

Abeona Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update

CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

Private Wellness Club Continuum Unlocks Final Membership Tier at West Village Flagship

Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

KLAS Report Shows Strong Early Results for TrustCommerce Cloud Payments

BioFlorida Announces Appointment of Dr. Anthony Japour, CEO of iTolerance, Inc., as Chair of the Southeast Chapter

Did You Know?

Editor’s Picks

Latest News

Fresh Off The press

You may have missed